Market requirements · DK
Denmark
Laegemiddelstyrelsen maintains standing warnings, including on Melanotan. Research-chemical framing is addressed in national coverage rather than in a dedicated regulator notice.
Buyers in this market search for: peptider engros forskning B2B leverandoer.
| Tell us the compounds you need for Denmark. | Ask about Denmark |
The regime
How compounds are classified in Denmark
| Governing law and regulator | Laegemiddelstyrelsen (the Danish Medicines Agency) is the applicable regulator, maintaining standing warning pages against named substances and running general illegal-medicines enforcement. |
|---|---|
| What the regulator stated | Laegemiddelstyrelsen states Melanotan's effectiveness is undocumented and side-effect studies are missing, and that it is not approved in Denmark, the EU, or the US, with documented risks including nausea, mole darkening, and a possible increased melanoma risk. |
| Research chemical framing | Danish media coverage (videnskab.dk) states many products sold online as research chemicals labelled 'not approved for human use' are in practice packaged, dosed, and marketed for human use - the same form-over-label logic found in every other market in this research. |
| Prescription-only compounds (GLP-1) | Semaglutide is confirmed as a prescription-only medicine, the active substance in Ozempic/Wegovy, and the agency warns against buying weight-loss medicines online outside legal channels due to counterfeiting and dosing risk. The direct prescription-only quote for semaglutide comes from a secondary outlet (Junia.dk), not a directly retrieved Laegemiddelstyrelsen statement, though it is corroborated qualitatively by the agency's general illegal-medicines warning. |
| Enforcement posture | Laegemiddelstyrelsen registered 8 illegal-trade cases in 2025 so far at the time of the underlying article, with 3 referred to police, and states selling medicines on social media is illegal and punishable. This figure is general illegal-medicines context, not peptide-specific. |
| Already supplying Denmark? Send the compounds and volumes you buy today and we will quote against them. | Send your list |
Your obligations
What a buyer in Denmark needs settled
- Do not sell semaglutide, tirzepatide, or other GLP-1 compounds as research peptides into Denmark -
- Assume Melanotan is carrying an active, standing regulator warning and do not offer it under any framing.
- Expect elevated scrutiny of social-media-driven marketing - both the regulator and national broadcaster TV2 have flagged peptide use spreading via social media.
- Confirm HGH/HCG status directly before entry, since no direct Laegemiddelstyrelsen statement on either was found.
We will ask about this at enquiry. We check the authorisations your activity requires before quoting, and we confirm the position per compound rather than for the market as a whole.
Sources
Check this yourself
Every position above traces to a dated public document. The authority, the document, the date and the link are below.
| Authority and document | Date | Link |
|---|---|---|
| Laegemiddelstyrelsen Warning against the self-tanning product Melanotan | undated | laegemiddelstyrelsen.dk/da/apoteker/medicin-indfoert-fra-u... |
| Laegemiddelstyrelsen Second warning page against the Melanotan product | undated | laegemiddelstyrelsen.dk/da/apoteker/medicin-indfoert-fra-u... |
| Laegemiddelstyrelsen Illegal trade in counterfeit medicine growing in the EU, risk to public health (8 cases in 2025) | 2025 | laegemiddelstyrelsen.dk/da/nyheder/2025/ulovlig-handel-med... |
| videnskab.dk Secondary media coverage: beauty trend out of control, peptides injected under the skin | undated | videnskab.dk/krop-sundhed/skoenhedstrend-uden-for-kontrol-... |
| TV2 Secondary national broadcaster coverage of peptide use as a concerning fitness trend on social media | January 2026 | nyheder.tv2.dk/krimi/2026-01-27-bekymrende-fitness-trend-s... |
Links go to the issuing body wherever one exists. Positions change. If you are relying on any of this, check the source rather than this page.
Market brief
Take the Denmark brief as a PDF
The regime, the buyer obligations and all 5 sources, dated and linked, in one document you can forward.
Same region
Nordics
Buyers supplying one of these usually supply the others. The requirements are not the same.
Scope
How to use this page
A summary of the published regulatory position in Denmark as at 2026-08-20, written for procurement teams deciding how to source. Every source is dated and linked so it can be checked at origin.
It is not legal advice. Full terms of supply, including where responsibility sits, are set out in our terms of supply.
Questions
Supplying into Denmark
Do you supply into Denmark?
We supply businesses that hold the authorisations their activity requires. Whether a specific compound can be supplied into Denmark depends on that compound and on your authorisations, and we confirm it per compound at the enquiry stage.
Who carries the compliance obligation?
The importer of record and the party placing the product on the market, which is the buyer. We supply the batch documentation that supports your file. We cannot hold your authorisations for you.
How current is this page?
It was reviewed on 2026-08-20 and is scheduled for review again on 2026-11-18. Every source is dated and linked, so you can check the original.
We already supply into Denmark. What changes if we source from you?
The batch documentation. You receive a Certificate of Analysis per batch, which can be issued under your own brand. The import and market-placing responsibilities stay where they are.
Is this legal advice?
No. It is a summary of the regulatory positions those authorities have published, as at the review date above. Take advice in your own market before you rely on it.
Enquire about supply into Denmark
Tell us the compounds and your authorisations. We confirm per compound before anything ships.